<html><head></head><body><h1>Tafamidis</h1><p class="drug-subtitle"><b>Generic Name:</b> tafamidis (ta FAM id is)<br/><b>Brand Name:</b> <i>Vyndamax, Vyndaqel</i><br/><b>Dosage Forms:</b> oral capsule (61 mg; meglumine 20 mg)</p><ul class="ddc-anchor-links"><li>Uses</li>
<li>Warnings</li>
<li>What to avoid</li>
<li>Side effects</li>
<li>Dosage</li>
<li>Interactions</li></ul><h2 class="ddc-anchor-offset" id="uses">What is tafamidis?</h2><p>Tafamidis affects a protein called transthyretin (TTR, made primarily in the liver). Transthyretin-mediated amyloidosis (ATTR) is a condition in which abnormal deposits of TTR protein build-up in many parts of the body, interfering with normal function. A build-up of TTR in the heart can lead to heart failure.</p><p>People with hereditary ATTR amyloidosis have a DNA mutation that can be passed from one generation to the next. People with wild-type ATTR amyloidosis do not have abnormal DNA and cannot pass on the condition.</p><p>Tafamidis is used in adults with hereditary or wild type ATTR to treat cardiomyopathy (damage of the heart muscle) caused by a build-up of TTR.</p><p>Tafamidis may also be used for purposes not listed in this medication guide.</p><h2 class="ddc-anchor-offset" id="warnings">Warnings</h2><p>Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.</p><h2>Before taking this medicine</h2><p>Tell your doctor if you have ever had:</p><ul>
<li>
<p>liver disease.</p>
</li>
</ul><p>liver disease.</p><p>Your name may be listed on a Transthyretin Amyloidosis Outcome Survey registry to track the effects of tafamidis on your condition.</p><p><b>Tafamidis may harm an unborn baby.</b> Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.</p><p>If you become pregnant, tell your doctor or contact the manufacturer of tafamidis at 1-800-438-1985.</p><p>You should not breastfeed while using tafamidis.</p><h2>How should I take tafamidis?</h2><p>Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.</p><p>Vyndaqel and Vyndamax are not equivalent medicines and may not have the same dosing schedule.</p><p>Take either Vyndaqel or Vyndamax exactly as your doctor has recommended. Avoid medication errors by using only the form and strength your doctor prescribes.</p><p>Swallow the capsule whole and do not crush, chew, break, or open it.</p><p>You may take tafamidis with or without food.</p><p>Store at room temperature away from moisture and heat. Keep each capsule in the blister pack until you are ready to take a dose.</p><h2>What happens if I miss a dose?</h2><p>Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.</p><h2>What happens if I overdose?</h2><p>Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.</p><h2 class="ddc-anchor-offset" id="what-to-avoid">What should I avoid while taking tafamidis?</h2><p>Follow your doctor's instructions about any restrictions on food, beverages, or activity.</p><h2 class="ddc-anchor-offset" id="side-effects">Tafamidis side effects</h2><p>Get emergency medical help if you have <b>signs of an allergic reaction:</b> hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Less serious side effects may be more likely, and you may have none at all.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</p><h2 class="ddc-anchor-offset" id="dosage">Tafamidis dosing information</h2><p><b>Usual Adult Dose for Amyloidogenic Transthyretin Amyloidosis:</b></p><p>Tafamidis meglumine 20 mg: 4 capsules once a day (80 mg/day)<br/><br/>Tafamidis 6 mg: 1 capsule once a day (6 mg/day)<br/><br/>Comments: Tafamidis and tafamidis meglumine products are not substitutable on a per mg basis.<br/><br/>Use: For the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.<br/><br/></p><h2 class="ddc-anchor-offset" id="interactions">What other drugs will affect tafamidis?</h2><p>Other drugs may affect tafamidis, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.</p><h2>More about tafamidis</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>3 Reviews</li>
<li>Drug class: transthyretin stabilizers</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Amyloid Cardiomyopathy</li>
</ul><h2>Further information</h2><p>Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.</p><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p><p class="ddc-copyright">Copyright 1996-2021 Cerner Multum, Inc. Version: 1.01.</p></body></html>